These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4395389)

  • 1. [Comparative studies on the effect of 2 beta receptor blockaders on elevated blood pressure and kidney function].
    Anlauf M; Heimsoth V; Ulrych M; Bock KD
    Verh Dtsch Ges Inn Med; 1969; 75():169-72. PubMed ID: 4395389
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of -adrenoceptor antagonists on the decline of the chronotropic response to isoprenaline.
    Fenyvesi T; George CF; Dollery CT
    J Pharm Pharmacol; 1972 Apr; 24(4):313-7. PubMed ID: 4402839
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
    Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
    Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of 1-isopropylamino-3-(4-indanoxy)-2-propanol (USVC 6524), an adrenergic -receptor blocking agent.
    Marmo E; Saini RK; Caputi AP
    Farmaco Prat; 1972 Dec; 27(12):661-87. PubMed ID: 4405106
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 7. Raised serum-lipids unaffected by beta-blockade.
    Lloyd-Mostyn RH; Krikler DM
    Lancet; 1970 Nov; 2(7681):1040. PubMed ID: 4098084
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basis for the use of beta-receptor blockaders in the practice].
    Blankart R
    Schweiz Rundsch Med Prax; 1973 Aug; 62(32):975-8. PubMed ID: 4147247
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of two new beta-blocking drugs on heart rate and blood pressure during passive tilting in man.
    Fuccella LM; Reban J; Bassini F; Lattes E; Mandelli V
    Eur J Clin Pharmacol; 1971 Dec; 4(1):12-7. PubMed ID: 4402874
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of propranolol upon the hemoglobin-oxygen dissociation curve.
    Pendleton RG; Newman DJ; Sherman SS; Brann EG; Maya WE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):647-56. PubMed ID: 4401159
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrophysiological evaluation of anesthetic actions of some beta-adrenergic blockers on guinea-pig cardiac muscles.
    Washizu Y
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):263-9. PubMed ID: 4144372
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased plasma renin activity induced in rats by physostigmine and effects of alpha- and beta-receptors blocking drugs thereon.
    Alexandre JM; Menard J; Chevillard C; Schmitt H
    Eur J Pharmacol; 1970 Sep; 12(1):127-31. PubMed ID: 4394344
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficiency of myocardial performance and oxidation of exogenous 14C-substrates under the influence of beta-receptor stimulating and blocking agents, as compared with other cardioactive drugs].
    Range H; Bischoff M; Siess M
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):432-3. PubMed ID: 4397506
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.
    Mazurkiewicz-Kwilecki IM; Romagnoli A
    J Pharm Pharmacol; 1970 Mar; 22(3):235-7. PubMed ID: 4399498
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-blocking drugs and human platelet aggregation in vitro.
    Gibelli A; Montanari C; Bellani D; Mandelli V; Sacchetti G
    Experientia; 1973 Feb; 29(2):186-7. PubMed ID: 4144249
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of six adrenergic beta receptor blockaders on auriculo-ventricular conduction in the dog].
    Giudicelli JF; Boissier JR
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):287-92. PubMed ID: 4402114
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies with the beta-receptor blockaders LB 46 and propranolol in healthy persons using the isoproterenol test].
    Bender F; Dotterweich K
    Med Welt; 1971 Sep; 22(37):1444-6. PubMed ID: 4398359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.